Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab

Autor:	Charles R. M. Bangham, Sophie Sagawe, Lucy Cook, Jana Haddow, Richard Dillon, Paul Fields, Alexandra J. Marks, Aviva Witkover, Graham P. Taylor, Jocelyn Turpin, Aileen G. Rowan, Maria A Demontis, Anat Melamed
Přispěvatelé:	Section of Virology - Department of Medicine - Faculty of Medicine, Imperial College London, Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, National Centre for Human Retrovirology at Imperial College NHS Trust, St Mary's Hospital, Skin Tumour Unit, Guys' Hospital, Department of Haematology, Guys' Hospital, Imperial College Healthcare NHS Trust- BRC Funding, Wellcome Trust
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Adult Leukemia lymphoma [SDV]Life Sciences [q-bio] Immunology Antineoplastic Agents Antibodies Monoclonal Humanized 03 medical and health sciences Remission induction 0302 clinical medicine Mogamulizumab medicine Humans Leukemia-Lymphoma Adult T-Cell In patient Online Only Articles 1102 Cardiorespiratory Medicine and Haematology ComputingMilieux_MISCELLANEOUS 030304 developmental biology 0303 health sciences Clinical Trials as Topic biology business.industry Remission Induction Hematology Prognosis 3. Good health Chronic disease 030220 oncology & carcinogenesis Monoclonal Chronic Disease biology.protein Antibody business Chronic Adult T-Cell Leukemia/Lymphoma medicine.drug
Zdroj:	Haematologica Haematologica, Ferrata Storti Foundation, 2019, 104 (12), pp.e566-e569. ⟨10.3324/haematol.2019.219253⟩ e569 e566
ISSN:	0390-6078 1592-8721
DOI:	10.3324/haematol.2019.219253⟩
Popis:	International audience
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2a8a63dd27bcba3349916a5893c304 https://hal.inrae.fr/hal-03183799 Zobrazit plný text záznamu